↓ Skip to main content

NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives

Overview of attention for article published in Frontiers in immunology, May 2018
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news
1 news outlet
blogs
1 blog
policy
1 policy source
twitter
15 X users
patent
3 patents
wikipedia
1 Wikipedia page

Citations

dimensions_citation
278 Dimensions

Readers on

mendeley
416 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives
Published in
Frontiers in immunology, May 2018
DOI 10.3389/fimmu.2018.00947
Pubmed ID
Authors

Remy Thomas, Ghaneya Al-Khadairi, Jessica Roelands, Wouter Hendrickx, Said Dermime, Davide Bedognetti, Julie Decock

X Demographics

X Demographics

The data shown below were collected from the profiles of 15 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 416 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 416 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 72 17%
Researcher 53 13%
Student > Bachelor 51 12%
Student > Master 35 8%
Other 22 5%
Other 51 12%
Unknown 132 32%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 88 21%
Medicine and Dentistry 48 12%
Immunology and Microbiology 44 11%
Agricultural and Biological Sciences 33 8%
Pharmacology, Toxicology and Pharmaceutical Science 22 5%
Other 40 10%
Unknown 141 34%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 34. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 January 2024.
All research outputs
#1,190,710
of 26,017,215 outputs
Outputs from Frontiers in immunology
#1,039
of 32,223 outputs
Outputs of similar age
#25,572
of 343,040 outputs
Outputs of similar age from Frontiers in immunology
#29
of 714 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,223 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.5. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 343,040 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 714 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.